A carregar...
Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis
BACKGROUND: Natalizumab (NTZ) is sometimes discontinued in patients with multiple sclerosis, mainly due to concerns about the risk of progressive multifocal leukoencephalopathy. However, NTZ interruption may result in recrudescence of disease activity. OBJECTIVE: The objective of this study was to s...
Na minha lista:
| Publicado no: | Ther Adv Neurol Disord |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6444403/ https://ncbi.nlm.nih.gov/pubmed/30956686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286419837809 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|